Status:

UNKNOWN

Measuring of Neuro-visual Functionality With Ocusweep

Lead Sponsor:

Ocuspecto Oy

Conditions:

Visual Impairment

Eligibility:

All Genders

18-95 years

Phase:

NA

Brief Summary

The aim of this study is to measure visual acuity, contrast sensitivity and visual field by SAP-method using a novel device Ocusweep compared to currently widely used methods. Addition to that, the ai...

Eligibility Criteria

Inclusion

  • Healthy volunteers
  • Persons suffering diagnosed eye disease
  • Persons suffering diagnosed brain disease

Exclusion

  • No diabetes
  • Only one diagnosed disease

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

600 Patients enrolled

Trial Details

Trial ID

NCT02258113

Start Date

November 1 2014

End Date

December 31 2022

Last Update

June 17 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ocuspecto Oy

Turku, Finland, 20100